Russia develops lung cancer vaccine
The Gamaleya Research Institute in Russia has developed a prototype vaccine specifically designed to treat non-small cell lung cancer as part of its efforts to advance innovative immunotherapies for cancer. The research program aims to develop vaccines for bladder, colon, and rectal cancers, with the goal of stimulating the immune system to recognize and effectively attack cancerous cells.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)